Current Report Filing (8-k)
September 09 2016 - 4:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 7, 2016
Growblox Sciences, Inc.
(Exact name of Registrant as specified in its charter)
Delaware
(State or other Jurisdiction of
Incorporation or organization)
|
000-55462
(Commission File Number)
|
59-3733133
(IRS Employer I.D. No.)
|
3550 W. Teco Avenue
Las Vegas, Nevada 89118
Phone: (844) 843-2569
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)
☐
Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))
ITEM 3.02 Unregistered Sales of Equity Securities.
Since the filing of its last quarterly report with the Securities and Exchange Commission, the Registrant has issued a total of 7,097,000 units to a total of 21 entities or individuals. Each unit consists of one common share of the Registrant and one warrant to purchase one share of common stock at the exercise price of $0.60 per share for five years. The units were sold for $0.20 per unit for total proceeds of $1,419,400. The issuance was exempt from the registration requirements of Section 5 of the Securities Act of 1933 pursuant to Section 4(2) of the same Act since the issuance of the Shares did not involve any public offering and did not involve any general solicitation.
SIGNATURE PAGE
Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Growblox Sciences, Inc.
|
|
|
|
|
|
|
Dated: September 9, 2016
|
|
By:
|
/s/ Ksenia Griswold
|
|
|
|
|
Ksenia Griswold
|
|
|
|
|
Chief Financial Officer
|
|
GB Sciences (CE) (USOTC:GBLX)
Historical Stock Chart
From Oct 2024 to Nov 2024
GB Sciences (CE) (USOTC:GBLX)
Historical Stock Chart
From Nov 2023 to Nov 2024